AEON Biopharma Inc (AMEX: AEON) is -77.69% lower on its value in year-to-date trading and has touched a low of $0.10 and a high of $17.17 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The AEON stock was last observed hovering at around $0.13 in the last trading session, with the day’s loss setting it -0.01%.
Currently trading at $0.12, the stock is -14.54% and -71.12% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.87 million and changing -3.75% at the moment leaves the stock -89.72% off its SMA200. AEON registered -98.33% loss for a year compared to 6-month loss of -88.19%. The firm has a 50-day simple moving average (SMA 50) of $0.4262 and a 200-day simple moving average (SMA200) of $1.20411.
The stock witnessed a -78.82% gain in the last 1 month and extending the period to 3 months gives it a -86.31%, and is 0.42% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 8.63% over the week and 19.77% over the month.
AEON Biopharma Inc (AEON) has around 10 employees, a market worth around $9.64M and $0.00M in sales. Distance from 52-week low is 18.95% and -99.30% from its 52-week high.
, but quarterly earnings will post 0.00% year-over-year. Quarterly sales are estimated to shrink 0.00% in year-over-year returns.
34.0 institutions hold shares in AEON Biopharma Inc (AEON), with institutional investors hold 51.98% of the company’s shares. The shares outstanding are 79.97M, and float is at 47.52M with Short Float at 2.51%. Institutions hold 33.14% of the Float.
